Neal Walker, Director at Aclaris Therapeutics, Inc. (ACRS), sold 33,121 shares at $16.88 ($553K) on 2023-02-02, disclosed to the SEC on 2023-02-03.
Seasonal sale ($553k) by Director — this insider has traded ACRS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.75 | 25,000 | $419K | 75.8% |
| 2 | $14.57 | 1,079 | $16K | 2.8% |
| 3 | $15.55 | 600 | $9K | 1.7% |
| 4 | $16.88 | 3,121 | $53K | 9.5% |
| 5 | $16.88 | 3,121 | $53K | 9.5% |
| 6 | $17.54 | 200 |
| $4K |
| 0.6% |
| Total | $16.69 avg | 33,121 | $553K | 100% |
| Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |
| ACRS | SELL | 2022-02-11 | $46K | — | Filing → |